Next-Gen MES: Modular Digitalization For Life Sciences Manufacturing

By Shawn Opatka, Vice President & GM Life Sciences at Honeywell

In the life sciences industry, one of the biggest takeaways from recent years is the realization that the world doesn't wait. The escalating production demands and pressures brought about by unforeseen crises like the COVID-19 pandemic can make implementing traditional monolithic MES (manufacturing execution systems) solutions impractical in terms of time, cost, and manufacturing flexibility.

Innovative solutions that can be rapidly deployed are needed, as they enable the efficient and flexible production of new biologics and other products. Next-generation MES solutions answer this challenge, offering life sciences manufacturers a systematic approach to digitize their manufacturing ecosystem that guarantees agility, business continuity, and effective change management.